FierceBiotech
@fiercebiotech
The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
ID: 18294197
http://FierceBiotech.com 21-12-2008 22:21:58
29,29K Tweet
101,101K Takipçi
636 Takip Edilen
“No one was saying 2025 was going to be an awesome year for biotech IPOs, in particular,” Adam Farlow, Global Chair of Baker McKenzie’s Capital Markets Practice Group, told James Waldron. “Last week's announcements created additional volatility. Equity markets hate volatility,